Use of G-CSF for Bone Marrow Graft Mobilization Increases NK Cell, Treg and Inkt Cell Graft Content, Possibly Lowering the Risk of Severe Acute Gvhd and Chronic Gvhd in HLA-Haploidentical Bone Marrow Transplantation (BMT) with Post-Transplantation Cyclophosphamide (PT-CY)